Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
07/2010
07/14/2010CN101775011A N-substituted phenyl-3-methylene heterocyclic arene-2,5-dimethylpyrrole compound and application thereof in anti-HIV/AIDS
07/13/2010US7754890 Arylsulfones and uses related thereto
07/13/2010US7754886 N-acylsulfonamide apoptosis promoters
07/13/2010US7754885 tubulysin derivatives used as antitumor agents
07/13/2010US7754880 enhanced characteristics in terms of herbicidal activity with respect to weeds and/or in terms of lower phytotoxicity for crops of agricultural interest; methyl (2E)-4-{2-chloro-4-fluoro-5-[1,2,3,6-tetrahydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)pyrimidin-1-yl]phenoxy}-3-methoxybut-2-enoate
07/13/2010US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12)
07/13/2010US7754745 [3-(2-{(3S)-3-[2-(Trifluoromethyl)phenoxy]pyrrolidin-1-yl}-1,3-thiazol-5-yl)-1,2,4-oxadiazol-5-yl]methanol, useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disorders, atherosclerosis, obesity, diabetes and fatty liver
07/13/2010US7754743 Heteroarylcarbamoylbenzene derivatives
07/13/2010US7754741 nonphytotoxic of N-[2-(3-Chloro-5-trifluoromethyl-pyridin-2-yl) ethyl]-2-trifluoromethyl-nicotinamide, used for controlling phytopathogenic fungi selected from Alternaria and Pyrenophora
07/13/2010US7754737 such as N-(1-amino-3-cyclohexylpropan-2-yl)-3-(1-hydroxy-1-phenylpentyl)piperidine-1-carboxamide, used in the treatment of cardiovascular, metabolic and cognitive disorders, aldosteronism, hypertension and anxiety
07/13/2010US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2)
07/13/2010US7754727 Hypotensive agents; atherosclerosis; congestive heart failure; hypertrophy; cardiomyopathy; diabetic nephropathy; restenosis; cognition activator; Alzheimer's disease; anxiolytic agents
07/13/2010US7754723 Therapeutic agents useful for treating pain
07/13/2010US7754719 Substituted piperidine derivatives as somatostatin SST1 receptor antagonists
07/13/2010US7754681 for linking drug moieties to ligands; comprises a peptide sequence that is a substrate for an intracellular enzyme, for example a cathepsin, that cleaves the peptide at an amide bond
07/13/2010CA2567776C Vasopressin v1a antagonists
07/13/2010CA2539546C Isoquinoline potassium channel inhibitors
07/13/2010CA2448303C Biologically active methylene blue derivatives
07/13/2010CA2432211C Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient
07/13/2010CA2409697C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/13/2010CA2368582C Pesticidal triazine derivatives
07/08/2010WO2010078408A1 Heteroaryl compounds useful as raf kinase inhibitors
07/08/2010WO2010077947A1 Phthalazinone and related analogs as sirtuin modulators
07/08/2010WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010WO2010077680A2 Compositions of protein receptor tyrosine kinase inhibitors
07/08/2010WO2010077101A2 Novel thiazolidinedione derivative and use thereof
07/08/2010WO2010076884A1 Novel fused ring compound and use thereof
07/08/2010WO2010076034A1 Toluidine sulfonamides and their use as-inhibitors
07/08/2010WO2010075957A1 Substituted furancarboxamides, and use thereof
07/08/2010WO2010075760A1 Heterocyclic nitrogenous compounds with insecticidal activity, their preparation methods and uses thereof
07/08/2010WO2010055164A3 Isoquinolone derivatives as inhibitors of plavivirus replication
07/08/2010WO2010012806A3 Substituted indole sulfonamide compounds, their preparation and use as medicaments
07/08/2010WO2010009139A3 Imidazolylpyrimidine compounds as hdac and / or cdk inhibitors
07/08/2010US20100174076 Coumarin derivatives useful as tnf alpha inhibitors
07/08/2010US20100173950 Heteroaryl (substituted)alkyl n-substituted sulfoximines as insecticides
07/08/2010US20100173917 Urea derivatives as abl modulators
07/08/2010US20100173897 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
07/08/2010US20100173891 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
07/08/2010US20100173851 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
07/08/2010CA2748274A1 Heteroaryl compounds useful as raf kinase inhibitors
07/08/2010CA2747640A1 Substituted furancarboxamides, and use thereof
07/08/2010CA2747158A1 Phthalazinone and related analogs as sirtuin modulators
07/08/2010CA2746221A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010CA2746220A1 Compositions of protein receptor tyrosine kinase inhibitors
07/07/2010EP2203448A1 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical
07/07/2010EP2203445A1 Azabicyclo ý3. 1. o¨hexyl derivatives as modulators of dopamine d3 receptors
07/07/2010EP2203438A1 Cyanoisoquinoline
07/07/2010EP2203437A1 Chiral cis-imidazolines
07/07/2010EP2203436A1 Pyrazine derivatives and their use as potassium channel modulators
07/07/2010EP2203431A1 Anti-infective pyrimidines and uses thereof
07/07/2010EP2203429A1 Pyridazinone derivatives and use thereof as p2x7 receptor inhibitors
07/07/2010EP2203427A2 5-aryl-4,5-dihydro-(1h)-pyrazoles as cannabinoid cb1 receptor agonists
07/07/2010EP2203424A1 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
07/07/2010CN101772495A fungicide 2-pyridyl-methylene-thio carboxamide or 2-pyridyl-methylene-n-substituted carboximidamide derivatives
07/07/2010CN101772493A gamma secretase modulators
07/07/2010CN101772486A Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives
07/07/2010CN101768157A Amantadine pidotimod carboxylate and preparation method and application thereof
07/07/2010CN101768156A Pidotimod arginine salt and preparation thereof
07/07/2010CN101768155A Derivatives containing (aminomethyl-five-membered heterocyclo-4-carbonyl)-pyrrolidine-2-carboxylic acid, preparation method thereof and use thereof
07/07/2010CN101768138A Organic micro-molecular film containing protonized nitrogen atoms and preparation method thereof
07/07/2010CN101768132A Biphenyl compound and preparation method and purposes thereof
07/07/2010CN101768131A Method for hydrogenating o-nitryl phenoxyl carbonyl compound to prepare a derivative of benzo morpholines
07/07/2010CN101768130A Derivatives containing aminomethyl-5-membered aromatic heterocycle-4-carboxylic acid, preparation method, drug combination and application thereof
07/07/2010CN101768129A Production intermediate of isoxazoline-substituted benzamide compound
07/07/2010CN101039939B Quinazolinylmethylene thiazolinones as CDK1 inhibitors
07/06/2010US7750164 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
07/06/2010US7750160 inhibit p38, MAP kinase interacting serine/threonine kinase 2 (MKNK2 kinase) and serine-threonine kinases (STKs); treating proliferative diseases including cancer, leukemias; e.g. N-(isoxazolyl)urea compounds and thiourea compounds
07/06/2010US7750154 Amide derivatives
07/06/2010US7750150 Process for producing acid adduct salt of polyacidic base compound
07/06/2010US7750006 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis
07/06/2010CA2248242C Malononitrile-derivative anion salts, and their uses as ionic conducting materials
07/06/2010CA2177858C Benzimidazole derivatives, their preparation and their therapeutic use
07/01/2010WO2010075270A1 4, 6-disubstituted 2-amino-pyrimidines as histamine h4 receptor modulators
07/01/2010WO2010075200A1 7-phenoxychroman carboxylic acid derivatives
07/01/2010WO2010074807A1 3, 4-dihydroquinolin-2 ( 1h ) -one derivatives as sodium channel modulators
07/01/2010WO2010074326A1 Probe for a biological specimen and labelling method and screening method using the probe
07/01/2010WO2010074325A1 Labeling composition for intraocular tissue, labeling method of intraocular tissue, and screening method
07/01/2010WO2010074244A1 Isoquinoline derivative
07/01/2010WO2010074110A1 Method for producing cyclic aminobenzoic acid derivative
07/01/2010WO2010073255A1 Process for preparing ziprasidone
07/01/2010WO2010072742A1 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
07/01/2010WO2010072607A1 Dihydropyridone amides as p2x7 modulators
07/01/2010WO2010072599A1 Dihydropyridone ureas as p2x7 modulators
07/01/2010WO2010054024A3 1, 2 -thiazol yl derivatives as cannabinoid receptor ligands
07/01/2010WO2010033977A3 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
07/01/2010US20100168422 Methods and intermediates useful in the synthesis of hexahydrofuro [2,3-b]furan-3-ol
07/01/2010US20100168419 Diacylglycerol Acyltransferase Inhibitors
07/01/2010US20100168416 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
07/01/2010US20100168189 Therapeutic substituted lactams
07/01/2010US20100168185 Use of 5-pyridin-4-yl-1,3-thiazoles for controlling phytopathogenic fungi
07/01/2010US20100168182 Compounds and compositions as kinase inhibitors
07/01/2010US20100168179 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
07/01/2010US20100168167 Piperidinones Useful in the Treatment of Inflammation
07/01/2010US20100168134 Pyridyl piperidine orexin receptor antagonists
07/01/2010US20100168124 Novel heterocyclic substituted pyridine compounds with cxcr3 antagonist activity
07/01/2010US20100168108 Phenyl derivatives and methods of use
07/01/2010US20100168107 Imidazole compounds for the treatment of neurodegenerative disorders
07/01/2010US20100168104 Hiv inhibiting 5-amido substituted pyrimidines
07/01/2010US20100168101 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
07/01/2010US20100168097 Non-Nucleoside Reverse Transcriptase Inhibitors